{
  "ticker": "LLY",
  "target_date": "2025-09-29",
  "actual_date": "2025-09-29",
  "collected_at": "2025-12-08T12:20:24.287555",
  "price": {
    "open": 724.49,
    "high": 726.79,
    "low": 715.03,
    "close": 725.4446411132812,
    "volume": 3309200,
    "change_1d_pct": 0.27,
    "change_7d_pct": -4.77,
    "change_30d_pct": 3.61
  },
  "technicals": {
    "rsi_14": 38.4,
    "sma_20": 743.71,
    "sma_50": 732.55,
    "macd": 0.247,
    "macd_signal": 4.291,
    "macd_histogram": -4.044,
    "bb_upper": 771.44,
    "bb_lower": 715.98,
    "price_vs_sma20_pct": -2.46,
    "price_vs_sma50_pct": -0.97,
    "volume_ratio": 0.99
  },
  "fundamentals": {
    "market_cap": 892435955712,
    "pe_ratio": 48.775833,
    "forward_pe": 43.93269,
    "price_to_book": 37.48173,
    "price_to_sales": 15.019168,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.47,
    "pct_from_52w_low": 59.59
  },
  "macro": {
    "spy": {
      "price": 663.68,
      "change_1d_pct": 0.28,
      "change_7d_pct": -0.0
    },
    "vix": {
      "level": 16.12,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.14
    },
    "dollar_index": {
      "level": 97.91
    },
    "gold": {
      "price": 3820.9
    },
    "regime": "SIDEWAYS"
  },
  "news": [
    {
      "headline": "Tracking The ~$14B Lone Pine Capital Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1759174911,
      "summary": "Get the latest on Lone Pine Capital's Q2 2025 portfolio: top stock picks, new investments, major exits, and strategic moves.",
      "url": "https://finnhub.io/api/news?id=bd162d0a96d9e4d5d5a33f24a441e963314dabe3f7877563f2f631cea6755c3f"
    },
    {
      "headline": "Alexandria & Lilly Unite at San Diego's One Alexandria Square",
      "source": "Yahoo",
      "datetime": 1759169700,
      "summary": "ARE and Lilly open Lilly Gateway Labs in San Diego, expanding biotech innovation with advanced labs and collaborative space.",
      "url": "https://finnhub.io/api/news?id=6d81e9090436c13deaa2fbfedca802ae50a5d4f73af7fb7781e5b85013f2cb70"
    },
    {
      "headline": "Weight Loss Wars: Is Novo Nordisk\u2019s Dominance Safe Against Eli Lilly?",
      "source": "Yahoo",
      "datetime": 1759163637,
      "summary": "As the battle for dominance heats up in the weight loss market, which stock is a better investment now?",
      "url": "https://finnhub.io/api/news?id=519ce986b09d585e829d71f6681360b42cf39b3d235d85fe2645863775a4165e"
    },
    {
      "headline": "How Eli Lilly (LLY) Balances Dividend Payouts With Long-Term Innovation",
      "source": "Yahoo",
      "datetime": 1759163602,
      "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 11 Best Value Dividend Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) , which has been around since the late 1800s, has built a strong track record in developing and selling drugs for diabetes, cancer, and immunology, including treatments f",
      "url": "https://finnhub.io/api/news?id=b2e315cdd6158d8c9560d2be8c8eb7e3dc7624249f4f7e49558f90eda19a932f"
    },
    {
      "headline": "Trials to watch: Three major catalysts in Alzheimer\u2019s disease",
      "source": "Yahoo",
      "datetime": 1759155799,
      "summary": "While Lilly and Eisai/Biogen have validated the amyloid theory, there is an unmet need for drugs with alternative mechanisms of action.",
      "url": "https://finnhub.io/api/news?id=2c47ac85e7346223b1ec78c54d1abfde6d411e2870e3bf003a77e55cc584bc53"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-22",
      "description": "xslF345X05/form4-09222025_040901.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000009/xslF345X05/form4-09222025_040901.xml"
    },
    {
      "form": "4",
      "date": "2025-09-19",
      "description": "xslF345X05/form4-09192025_040901.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000007/xslF345X05/form4-09192025_040901.xml"
    },
    {
      "form": "4",
      "date": "2025-09-17",
      "description": "xslF345X05/wk-form4_1758142191.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000004/xslF345X05/wk-form4_1758142191.xml"
    },
    {
      "form": "4",
      "date": "2025-09-17",
      "description": "xslF345X05/wk-form4_1758142140.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000242/xslF345X05/wk-form4_1758142140.xml"
    },
    {
      "form": "4",
      "date": "2025-09-17",
      "description": "xslF345X05/wk-form4_1758142082.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000006/xslF345X05/wk-form4_1758142082.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}